IL118188A0 - A pharmaceutical composition containing one or more plasma derivatives and methods for the preparation thereof - Google Patents

A pharmaceutical composition containing one or more plasma derivatives and methods for the preparation thereof

Info

Publication number
IL118188A0
IL118188A0 IL11818896A IL11818896A IL118188A0 IL 118188 A0 IL118188 A0 IL 118188A0 IL 11818896 A IL11818896 A IL 11818896A IL 11818896 A IL11818896 A IL 11818896A IL 118188 A0 IL118188 A0 IL 118188A0
Authority
IL
Israel
Prior art keywords
plasma derivatives
preparation
methods
pharmaceutical composition
plasma
Prior art date
Application number
IL11818896A
Other versions
IL118188A (en
Original Assignee
Immuno Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=3499516&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=IL118188(A0) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Immuno Ag filed Critical Immuno Ag
Publication of IL118188A0 publication Critical patent/IL118188A0/en
Publication of IL118188A publication Critical patent/IL118188A/en

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/70—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving virus or bacteriophage
    • C12Q1/701—Specific hybridization probes
    • C12Q1/706—Specific hybridization probes for hepatitis
    • C12Q1/707—Specific hybridization probes for hepatitis non-A, non-B Hepatitis, excluding hepatitis D
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/12—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
    • A61K35/14—Blood; Artificial blood
    • A61K35/16—Blood plasma; Blood serum
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/08—Plasma substitutes; Perfusion solutions; Dialytics or haemodialytics; Drugs for electrolytic or acid-base disorders, e.g. hypovolemic shock
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/70—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving virus or bacteriophage
    • C12Q1/701—Specific hybridization probes
    • C12Q1/702—Specific hybridization probes for retroviruses
    • C12Q1/703—Viruses associated with AIDS
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/70—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving virus or bacteriophage
    • C12Q1/701—Specific hybridization probes
    • C12Q1/706—Specific hybridization probes for hepatitis
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/96—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving blood or serum control standard
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
    • C12Q1/6844—Nucleic acid amplification reactions
    • C12Q1/6851—Quantitative amplification
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2496/00—Reference solutions for assays of biological material
    • G01N2496/05—Reference solutions for assays of biological material containing blood cells or plasma

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Organic Chemistry (AREA)
  • Immunology (AREA)
  • Zoology (AREA)
  • Hematology (AREA)
  • General Health & Medical Sciences (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Wood Science & Technology (AREA)
  • Virology (AREA)
  • Biotechnology (AREA)
  • Molecular Biology (AREA)
  • Analytical Chemistry (AREA)
  • Microbiology (AREA)
  • Physics & Mathematics (AREA)
  • Biochemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biomedical Technology (AREA)
  • Genetics & Genomics (AREA)
  • Cell Biology (AREA)
  • Biophysics (AREA)
  • Communicable Diseases (AREA)
  • Medicinal Chemistry (AREA)
  • General Engineering & Computer Science (AREA)
  • Veterinary Medicine (AREA)
  • Urology & Nephrology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pathology (AREA)
  • Diabetes (AREA)
  • Epidemiology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Developmental Biology & Embryology (AREA)
  • Food Science & Technology (AREA)
  • General Physics & Mathematics (AREA)

Abstract

The invention relates to a medicament containing one or more plasma derivatives as the active or auxiliary agent, in which the basic material or the intermediate products arising during the production of the plasma derivatives exert no viral stress on one or more differently proliferable haematogenic viruses or such an effect not exceeding a defined limit. The basic material or intermediate product for producing the final plasma derivative of which the quality is thus assured is subsequently subjected to at least one essential viral enrichment or inactivation step. The invention also describes a process for producing the medicament and the production of assured-quality basic materials or intermediate products.
IL11818896A 1995-05-08 1996-05-08 Drug containing one or more plasma derivatives a quality-assured plasma starting material for the same and a method for the preparation of the drug IL118188A (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
AT0077895A AT406019B (en) 1995-05-08 1995-05-08 METHOD FOR PRODUCING A MEDICINAL PRODUCT CONTAINING ONE OR MORE PLASMA DERIVATIVES

Publications (2)

Publication Number Publication Date
IL118188A0 true IL118188A0 (en) 1996-09-12
IL118188A IL118188A (en) 2000-07-16

Family

ID=3499516

Family Applications (1)

Application Number Title Priority Date Filing Date
IL11818896A IL118188A (en) 1995-05-08 1996-05-08 Drug containing one or more plasma derivatives a quality-assured plasma starting material for the same and a method for the preparation of the drug

Country Status (10)

Country Link
EP (1) EP0769954B2 (en)
JP (2) JPH10502943A (en)
AT (2) AT406019B (en)
CA (1) CA2191475C (en)
DE (1) DE59610626D1 (en)
DK (1) DK0769954T4 (en)
ES (1) ES2203688T5 (en)
IL (1) IL118188A (en)
NO (1) NO322186B1 (en)
WO (1) WO1996035437A1 (en)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5780222A (en) 1995-04-10 1998-07-14 Alpha Therapeutic Corporation Method of PCR testing of pooled blood samples
AT403477B (en) * 1996-04-30 1998-02-25 Immuno Ag BIOLOGICAL MATERIAL FREE OF VIRAL AND MOLECULAR PATHOGENES AND METHOD FOR THE PRODUCTION THEREOF
JP2002509694A (en) * 1997-11-04 2002-04-02 ロシュ ダイアグノスティックス ゲーエムベーハー Specific and sensitive nucleic acid detection method
DE19752898A1 (en) * 1997-11-28 1999-08-05 Centeon Pharma Gmbh Method for the detection of high concentrations of four in blood plasma and / or blood serum by means of the polymerase chain reaction
AT407160B (en) * 1998-06-04 2001-01-25 Immuno Ag METHOD FOR DETERMINING ANTIGENS
US6579537B2 (en) 1999-02-12 2003-06-17 Baxter Aktiengesellschaft Method for producing fibronectin and fibrinogen compositions using a polyalkylene glycol and glycine or β-alanine
AT410218B (en) 1999-08-20 2003-03-25 Baxter Ag METHOD FOR PRODUCING A QUALITY-ASSURED POOL OF BIOLOGICAL SAMPLES
EP1711513B1 (en) * 2003-12-01 2014-07-02 Novo Nordisk Health Care AG Nanofiltration of factor vii solutions to remove virus
DE102005054206B4 (en) * 2005-11-14 2010-07-15 Roth, Willi, Prof. Dr. Method and apparatus for automated processing of pooled samples
WO2017040831A1 (en) * 2015-09-02 2017-03-09 Ep Minerals, Llc Regeneration processes for media used in the treatment of fermented liquids

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0447984A1 (en) * 1990-03-20 1991-09-25 Abbott Laboratories Hyperimmune globulin against hepatitis C virus and method for making same
WO1992001714A1 (en) † 1990-07-24 1992-02-06 Yamanouchi Pharmaceutical Co., Ltd. Non-a non-b hepatitis virus antigen
JP3114731B2 (en) * 1990-08-14 2000-12-04 国立感染症研究所長 Peptide antigen for detecting hepatitis C virus antibody and method of using the same
JPH04300000A (en) * 1991-03-27 1992-10-23 Teijin Ltd Method for determining nucleic acid
AT402891B (en) * 1991-06-20 1997-09-25 Immuno Ag METHOD FOR PRODUCING AN INACTIVATED BLOOD PRODUCT
AU4248193A (en) † 1992-05-15 1993-12-13 New England Deaconess Hospital Quantitation of viral rna by competitive polymerase chain reaction
EP0586112A3 (en) * 1992-08-14 1994-09-14 Pharma Gen S A Control of pcr mediated detection of micro-organisms
ES2194843T3 (en) * 1992-09-11 2003-12-01 Hoffmann La Roche DETECTION OF NUCLEIC ACIDS IN BLOOD.
CA2159044A1 (en) * 1994-09-26 1996-03-27 Falko-Guenter Falkner Method of quantitating nucleic acids

Also Published As

Publication number Publication date
CA2191475A1 (en) 1996-11-14
AT406019B (en) 2000-01-25
NO970050D0 (en) 1997-01-07
EP0769954A1 (en) 1997-05-02
JP2008247913A (en) 2008-10-16
DE59610626D1 (en) 2003-09-04
ES2203688T5 (en) 2011-07-01
EP0769954B1 (en) 2003-07-30
WO1996035437A1 (en) 1996-11-14
ATE245989T1 (en) 2003-08-15
DK0769954T3 (en) 2003-11-17
DK0769954T4 (en) 2011-04-04
CA2191475C (en) 2010-09-14
ES2203688T3 (en) 2004-04-16
EP0769954B2 (en) 2011-03-09
JPH10502943A (en) 1998-03-17
IL118188A (en) 2000-07-16
ATA77895A (en) 1999-06-15
NO970050L (en) 1997-01-07
NO322186B1 (en) 2006-08-28

Similar Documents

Publication Publication Date Title
UA29450C2 (en) Derivatives of hydroxamic acid, a PROCESS for PREPARATION thereof, a method for influence on diseases and pharmaceutical composition containing them
HU9402232D0 (en) 1-benzene-sulfonyl-1,3-dihydro-indol-2-one derivatives, process for producing them and pharmaceutical compositions containing them
ZA966751B (en) Novel acyl derivatives of melatonin and of metalotoninergic analogues; process for their preparation and their use as medicinal products.
CZ58196A3 (en) Naphthyl derivative, process of its preparation, pharmaceutical composition containing and intermediate for preparing thereof
HUT70848A (en) 1-aminoethyl-indol derivatives, process for production thereof and pharmaceutical compositions comprising them
HUP9602511A2 (en) Aryl-diazinone derivatives, pharmaceutical compositions containing them, and process for producing all these
IL118188A0 (en) A pharmaceutical composition containing one or more plasma derivatives and methods for the preparation thereof
NZ320356A (en) Intermediary compounds for the hemisynthesis of taxanes and preparation processes therefor
HUT49113A (en) Process for producing 2-/2-hydroxy-3-phenoxy-propyl-amino/-ethyl-phenoxy-methyl-amido derivatives and pharmaceutical compositions containing them as active components
IL117091A0 (en) Methylphenyloxazolidinone derivatives pharmaceutical compositions containing the same and processes for the preparation thereof
EP0378208A3 (en) Production method for protein-containing composition
HUP9601358A3 (en) Fluoro-phenyl-substituted alkenyl-carboxylic-guanidines, process for producing them, their use as medicines or diagnostica, and pharmaceutical compositions containing them
HUP9601321A3 (en) Substituted (benzyloxy)-carbonyl-guanidine derivatives, process for producing them, pharmaceutical compositions containing them their use as pharmaceutical compositions or diagnostica, and the use of the said compds.
IL88971A (en) Disubstituted pyridines, process and intermediates, their preparation and pharmaceutical compositions containing them
HUP9602640A3 (en) Substituted benzoyl-guanidine derivatives, process for producing them, pharmaceutical compositions containing them and the use of the compds.
GR3020575T3 (en) New 2-amino-5-cyano-1,4-dihydropyridines, process for their preparation and use in pharmaceutical compositions
HUP9900105A3 (en) Momopiperazine derivatives, process for producing them and pharmaceutical compositions containing them
HUT58282A (en) Process for producing new, cyclic ketone derivatives and pharmaceutical compositions containing them as active components
UA29395C2 (en) Derivative of pregna-4,9(11),17(20)-trien-3-on, a process for preparation thereof, a process for preparation of 21-acyloxypregna-4,9(11),16-trien-3,20-dion and intermediary compounds
AU565799B2 (en) 4-oxothiazolidin-2-ylidene-acetamide derivatives
HUT59089A (en) Process for producing aniline derivatives and pharmaceutical composition containing them as active components
DE69736115D1 (en) PROCESS FOR PREPARING PURIFIED TRANSFERRIN
AU665866B2 (en) Androstane derivatives substituted by a quaternary ammonium group in 16-position, pharmaceutical compositions containing them and process for preparing same
HU9401914D0 (en) Piperidine- and piperazine derivatives, pharmaceutical compositions containing them as active components and process for producing both
HUP9600213A2 (en) 4-mercapto-benzoyl-guanidine derivatives, process for producing them and pharmaceutical compositions containing them

Legal Events

Date Code Title Description
FF Patent granted
KB Patent renewed
KB Patent renewed
KB Patent renewed
KB Patent renewed
KB Patent renewed
EXP Patent expired